Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 25 , ISSUE 4 ( April, 2021 ) > List of Articles

ORIGINAL RESEARCH

Prognostic Value of Immunosuppressive Acidic Protein and Oxidative Stress Status in Critically Ill Patients

Elif O Tutuncu, Zerrin D Dundar, Ibrahim Kilinc, Aziz Tutuncu, Sedat Kocak, Abdullah S Girisgin

Citation Information : Tutuncu EO, Dundar ZD, Kilinc I, Tutuncu A, Kocak S, Girisgin AS. Prognostic Value of Immunosuppressive Acidic Protein and Oxidative Stress Status in Critically Ill Patients. Indian J Crit Care Med 2021; 25 (4):405-410.

DOI: 10.5005/jp-journals-10071-23788

License: CC BY-NC 4.0

Published Online: 01-04-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Introduction: The aim of this study was to determine the prognostic value of admission immunosuppressive acidic protein (IAP), interleukin-6 (IL-6), total oxidant status (TOS), and total antioxidant status (TAS) in 161 critically ill patients. Materials and methods: This prospective observational study was carried out in the Emergency Department ICU for 6 months. Critically ill patients were included in the study consecutively. The main outcomes were the need for early mechanical ventilation (MV) and in-hospital mortality. Results: The mean age of 161 patients was 66.5 ± 17.1 years. The median IL-6 levels of patients who required early MV were significantly higher than of the patients who required no MV (p < 0.001), and the median IL-6 levels in the nonsurvivors were significantly higher than in the survivors (p < 0.001). The median IAP levels were not significantly different between the groups (p = 0.464 for early MV and p = 0.340 for the in-hospital mortality group). The AUCs of IL-6 and TOS for predicting in-hospital mortality were 0.819 and 0.608, respectively. Conclusion: The IAP level on admission to ICU is ineffective in predicting the need for early MV and in-hospital mortality; however, IL-6 level on admission is a strong prognostic predictor in critically ill patients. Our findings showed that the burden of oxidative stress was high in general ICU patients. Clinical significance: Our study showed that increased oxidative stress is an important problem in critically ill patients. If measures are taken to reduce oxidative stress by physicians, the prognosis of critically ill patients will be better.

HTML PDF Share
  1. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 2008;12:R101. DOI: 10.1186/cc6981.
  2. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003;31(4):1048–1052. DOI: 10.1097/01.CCM.0000055371.27268.36.
  3. Hawkins RB, Raymond SL, Stortz JA, Horiguchi H, Brakenridge SC, Gardner A, et al. Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome. Front Immunol 2018;9:1511. DOI: 10.3389/fimmu.2018.01511.
  4. Tamura K, Shibata Y, Matsuda Y, Ishida N. Isolation and characterization of a immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 1981;41:3244–3252.
  5. Sadahiro S, Suzuki T, Maeda Y, Tanaka A, Kamijo A, Murayama C, et al. Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. Anticancer Res 2010;30(3):993–999.
  6. Ebina T, Fujimiya Y. Cell transfer regimens in patients with highly advanced surgically unresectable non-small cell lung cancer: significantly improved overall survival in patients with lower levels of serum immunosuppressive acidic protein. Lung Cancer 2008;60(2):246–251. DOI: 10.1016/j.lungcan.2007.09.016.
  7. Araki K, Igarashi T, Tobe T, Mizoguchi K, Suzuki H, Furuya Y, et al. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy. Urology 2006;68(6):1178–1182. DOI: 10.1016/j.urology.2006.08.1071.
  8. Ikuta S, Miki C, Tanaka K, Konishi N, Mohri Y, Tonouchi H, et al. Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients. Dig Surg 2003;20(6):532–538. DOI: 10.1159/000073700.
  9. Ueyoshi A, Ota K. Evaluation of immunosuppressive acid protein (IAP) in patients with rheumatoid arthritis. Ryumachi 1992;32(2):131–134.
  10. Shinzeki M, Ueda T, Takeyama Y, Yasuda T, Sawa H, Nakajima T, et al. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis. Pancreas 2007;35(4):327–333. DOI: 10.1097/mpa.0b013e3181200222.
  11. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery 2000;127(3):329–336. DOI: 10.1067/msy.2000.103498.
  12. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 2001;136(3):328–333. DOI: 10.1001/archsurg.136.3.328.
  13. Rabus M, Demirbağ R, Sezen Y, Konukoğlu O, Yildiz A, Erel O, et al. Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. Turk Kardiyol Dern Ars 2008;36(8):536–540.
  14. Morelli NR, Scavuzzi BM, Miglioranza LHDS, Lozovoy MAB, Simão ANC, Dichi I. Metabolic syndrome components are associated with oxidative stress in overweight and obese patients. Arch Endocrinol Metab 2018;62(3):309–318. DOI: 10.20945/2359-3997000000036.
  15. Schrutka L, Goliasch G, Meyer B, Wurm R, Koller L, Kriechbaumer L, et al. Impaired high-density lipoprotein anti-oxidant function predicts poor outcome in critically ill patients. PLoS One 2016;11:e0151706. DOI: 10.1371/journal.pone.0151706.
  16. Ranjbar A, Solhi H, Mashayekhi FJ, Susanabdi A, Rezaie A, Abdollahi M. Oxidative stress in acute human poisoning with organophosphorus insecticides; a case control study. Environ Toxicol Pharmacol 2005;20(1):88–91. DOI: 10.1016/j.etap.2004.10.007.
  17. Dur A, Kocaman O, Koçyiğit A, Türkdoğan KA, Sönmez E, Keskin S, et al. Oxidative status and lymphocyte DNA damage inpatients with acute pancreatitis and its relationship with severity of acute pancreatitis. Turk J Gastroenterol 2016;27(1):68–72. DOI: 10.5152/tjg.2015.150317.
  18. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–119. DOI: 10.1016/j.clinbiochem.2003.10.014.
  19. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–1111. DOI: 10.1016/j.clinbiochem.2005.08.008.
  20. RelAssay. Oxidatıve Stress Measurement and Evaluation https://www.relassay.com/uploads/OxidativeGuideline.pdf [accessed 18 January 2019].
  21. Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, et al. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition. J Surg Oncol 2008;97(5):404–408. DOI: 10.1002/jso.20966.
  22. Kogure M, Kashimura S, Matsuyama S, Ohtani S, Saze Z, Odashima Y, et al. Prognostic role of immunosuppressive acidic protein in patients with esophageal cancer. Dis Esophagus 2008;21(3):214–219. DOI: 10.1111/j.1442-2050.2007.00754.x.
  23. Takahashi W, Nakada TA, Yazaki M, Oda S. Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock 2016;46(3):254–260. DOI: 10.1097/SHK.0000000000000616.
  24. Dieplinger B, Egger M, Leitner I, Firlinger F, Poelz W, Lenz K, et al. Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients. J Crit Care 2016;34:38–45. DOI: 10.1016/j.jcrc.2016.03.020.
  25. Fink-Neuboeck N, Lindenmann J, Bajric S, Maier A, Riedl R, Weinberg AM, et al. Clinical impact of interleukin 6 as a predictive biomarker in the early diagnosis of postoperative systemic inflammatory response after major thoracic surgery: A prospective clinical trial 2016;160(2):443–453. DOI: 10.1016/j.surg.2016.04.004.
  26. Mat-Nor MB, Md Ralib A, Abdulah NZ, Pickering JW. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. J Crit Care 2016;33:245–251. DOI: 10.1016/j.jcrc.2016.01.002.
  27. Atik İ, Kozacı N, Beydilli İ, Avcı M, Ellidağ H, Keşaplı M. Investigation of oxidant and antioxidant levels in patients with acute stroke in the emergency service. Am J Emerg Med 2016;34(12):2379–2383. DOI: 10.1016/j.ajem.2016.08.062.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.